CORT - Corcept Therapeutics Incorporated

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
401,858
401,858
365,978
353,874
306,486
Cost of revenue
5,385
5,385
5,281
5,582
5,504
Gross profit
396,473
396,473
360,697
348,292
300,982
Operating expenses
Research development
130,991
130,991
113,864
114,764
89,017
Selling general and administrative
152,848
152,848
122,356
105,326
100,359
Total operating expenses
283,839
283,839
236,220
220,090
189,376
Operating income or loss
112,634
112,634
124,477
128,202
111,606
Income before tax
116,191
116,191
125,006
131,602
116,676
Income tax expense
14,773
14,773
12,494
25,591
22,495
Income from continuing operations
101,418
101,418
112,512
106,011
94,181
Net income
101,418
101,418
112,512
106,011
94,181
Net income available to common shareholders
101,288
101,288
112,512
106,011
94,181
Basic EPS
-
0.95
0.97
0.92
0.82
Diluted EPS
-
0.87
0.89
0.85
0.77
Basic average shares
-
106,787
115,653
115,412
114,349
Diluted average shares
-
115,966
125,963
124,194
122,566
EBITDA
-
112,634
124,477
128,202
111,606